Oppenheimer analyst Suraj Kalia downgrades Edwards Lifesciences (NYSE:EW) from Outperform to Perform.
Key Takeaways From Permian Resources Analyst Ratings
Permian Resources (NYSE:PR) underwent analysis by 14 analysts in the last quarter, revealing a spectrum of viewpoints from…